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Mitochondrial Dysregulation 
Secondary to Endoplasmic 
Reticulum Stress in Autosomal 
Dominant Tubulointerstitial Kidney 
Disease – UMOD (ADTKD-UMOD)
Elisabeth Kemter1, Thomas Fröhlich2, Georg J. Arnold2, Eckhard Wolf 1,2 & Rüdiger Wanke3
‘Autosomal dominant tubulointerstitial kidney disease – UMOD’ (ADTKD-UMOD) is caused by impaired 
maturation and secretion of mutant uromodulin (UMOD) in thick ascending limb of Henle loop (TAL) 
cells, resulting in endoplasmic reticulum (ER) stress and unfolded protein response (UPR). To gain 
insight into pathophysiology, we analysed proteome profiles of TAL-enriched outer renal medulla 
samples from ADTKD-UMOD and control mice by quantitative LC-MS/MS. In total, 212 differentially 
abundant proteins were identified. Numerous ER proteins, including BiP (HSPA5), phosphorylated 
eIF2α (EIF2S1), ATF4, ATF6 and CHOP (DDIT3), were increased abundant, consistent with UPR. 
The abundance of hypoxia-inducible proteins with stress survival functions, i.e. HYOU1, TXNDC5 
and ERO1L, was also increased. TAL cells in ADTKD-UMOD showed a decreased proportion of 
mitochondria and reduced abundance of multiple mitochondrial proteins, associated with disturbed 
post-translational processing and activation of the mitochondrial transcription factor NRF1. Impaired 
fission of organelles, as suggested by reduced abundance of FIS1, may be another reason for disturbed 
biogenesis of mitochondria and peroxisomes. Reduced amounts of numerous proteins of the OXPHOS 
and citrate cycle pathways, and activation of the LKB1-AMPK-pathway, a sensor pathway of cellular 
energy deficits, suggest impaired energy homeostasis. In conclusion, our study revealed secondary 
mitochondrial dysfunction in ADTKD-UMOD.
‘Autosomal dominant tubulointerstitial kidney disease – UMOD’ (ADTKD-UMOD; formerly uromodulin-associated 
kidney disease - UAKD) is a progressive dominant hereditary chronic kidney disease (CKD)1,2 caused by amino acid 
changing mutations of the gene encoding the glycoprotein uromodulin (UMOD). UMOD, which is expressed selec-
tively in cells of the thick ascending limb of Henle’s loop (TAL) and of the early distal convoluted tubules3, is secreted 
and represents the most abundant protein in urine1. Impaired intracellular trafficking and intracellular accumulation 
of mutant UMOD protein causes TAL and consequently kidney dysfunction. Endoplasmic reticulum (ER) hyper-
plasia, induction of unfolded protein response (UPR) to increase folding capacity of the ER, and activation of NF-κ B 
signalling in the TAL segment are the so far known pathomechanisms of ADTKD-UMOD1,4.
Disease progression leads to end-stage renal failure requiring renal replacement therapy between the ages of 
25 and 70 years5. So far, only symptomatic therapeutic interventions can be done which do not prevent disease 
progression. A broader view into the molecular derangements in ADTKD-UMOD might be useful to develop 
novel therapeutic strategies. Therefore, we performed a holistic proteome analysis using quantitative liquid 
chromatography-tandem mass spectrometry (LC-MS/MS) of the affected kidney compartment in a well character-
ized mouse model for ADTKD-UMOD, the UmodC93F mutant mouse line6. Results of the holistic proteome study 
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were extended by Western blot analyses and immunohistochemical studies of UmodC93F mutant mice and a second 
ADTKD-UMOD mouse model with a less pronounced disease phenotype, the UmodA227T mutant mouse line.
Results
Quantitative LC-MS/MS analysis identified 212 differentially abundant proteins in ADTKD-
UMOD kidneys. Label free quantification (LFQ) of proteins from the outer medulla kidney samples of four-
month-old UmodC93F mutant mice and wild-type controls was performed. In total, 10,727 peptides were identified 
(PEP value <  0.05) which could be assigned to 1,987 protein groups at a false discovery rate (FDR) < 0.01. All 
identified proteins are listed in Supplementary Table 1.
Hierarchical clustering of LFQ values clearly separated the two genotype groups (Supplementary Fig. 1). 
In total, 212 proteins altered in abundance (adjusted p-value <  0.05; log2-fold change > |0.6|) were iden-
tified, 112 with increased and 100 with decreased abundance in UmodC93F mutant vs. wild-type mice 
(Supplementary Table 2).
Functional annotation clustering reveals alterations in the fractional composition of cellular 
organelles (ER, mitochondria, and peroxisomes) and in cellular energy metabolism. 
Differentially abundant proteins were clustered using DAVID analysis (Table 1, Supplementary Table 3) revealing 
that 30% of all identified differentially abundant proteins were located in mitochondria. Further cellular com-
ponent clusters with differentially abundant proteins were ER and peroxisomes. Functionally annotated clusters 
of differentially abundant proteins in ADTKD-UMOD were related to aerobic respiration and citrate cycle, ATP 
biosynthesis and metabolism, catabolic process of glucose and other monosaccharides, oxidative phosphorylation 
(OXPHOS), and NADH/NADPH oxidoreductase activity. A further category of differentially abundant proteins 
contained extracellular matrix proteins.
Disturbed ER homeostasis as a key feature of ADTKD-UMOD. Amino acid changing mutations in 
UMOD cause a defect of UMOD maturation and secretion, leading to intracellular perinuclear accumulation of 
immature UMOD (Fig. 1A) in the enlarged and stressed ER of TAL cells1,6. Significantly increased abundances 
of immature UMOD and of numerous ER-associated proteins were observed in the outer medulla of UmodC93F 
mutant mice, with TXNDC5 showing the highest abundance increase (log2 fold change: 2.0) (Fig. 1B and C, 
Supplementary Table 4). Next, we evaluated ER stress pathways in more detail and revealed, besides an increase 
of BiP (HSPA5), an increase of the translation initiation factor eIF2α (EIF2S1) and its activated phosphorylated 
form (Fig. 1D) in Umod mutant mice. As shown by Western blotting, the amounts of eIF2α target proteins ATF4 
and CHOP were also strongly increased. Furthermore, the full-length inactive and the cleaved active forms of 
ATF6 were increased abundant in ADTKD-UMOD. In summary, multiple proteins of the KEGG pathway ‘protein 
processing in ER’ were increased abundant in ADTKD-UMOD. These include proteins related to recognition 
by luminal chaperons (BiP, HYOU1, HSP90B1), to glycosylation (PDIA3, CALR, UGGT1), to intra-ER protein 
targeting (ERO1L, PDIA4, PDIA6, TXNDC5), and to the UPR pathway of ER stress (eIF2α , ATF4, ATF6, CHOP) 
(Supplementary Fig. 2).
Reduced abundances of mitochondrial proteins and alterations in cellular localization indicate 
mitochondrial dysfunction in TAL cells of ADTKD-UMOD kidneys. Nearly one third of the differ-
entially abundant proteins in ADTKD-UMOD are localized in mitochondria (Table 1), and most of them were 
reduced in abundance (Fig. 2A, Supplementary Table 5). The five mitochondrial proteins with increased abun-
dance in ADTKD-UMOD were ACSS1, MRPL12, LONP1, ACSM5 and UGT1A7C.
The mitochondrial protein SDHA, which is part of OXPHOS respiratory complex II, was selected for immu-
nolocalization. SDHA was significantly less abundant in the outer medulla of Umod mutant mice (Fig. 2B). In 
wild-type mice, SDHA was highly abundant in TAL segments (Fig. 2C, Supplementary Fig. 3A). Wild-type 
TAL cells showed a homogenous lamellar basal orientated cytoplasmic immunolocalization of SDHA, con-
sistent with mitochondrial localization in TAL cells in the basal labyrinth as seen by ultrastructural analyses 
(Fig. 2D). In contrast, SDHA staining of TAL segments of Umod mutant mice was heterogeneous (Fig. 2C, 
Enrichment score Term counts of DAPs % of all DAPs
33.29 mitochondrial part 64 30.0
13.59 oxidative phosphorylation 25 11.7
10.85 citrate cycle (TCA cycle) 12 5.6
9.47 endoplasmic reticulum part 17 8.0
6.31 ATP metabolic process 13 6.1
6.31 hydrogen ion transport 9 4.2
6.27 peroxisome 11 5.2
5.67 cation transmembrane transporter activity 11 5.2
4.78 NADH/NADPH oxidoreductase activity 8 3.8
4.47 glucose catabolic process 8 3.8
2.01 extracellular matrix 10 4.7
Table 1.  Selection of functional clusters of differential abundant proteins (DAPs) in ADTKD-UMOD, 
identified by DAVID annotation cluster enrichment analysis.
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Supplementary Fig. 3A). Few TAL cells of Umod mutant mice exhibited a SDHA staining intensity and pattern 
resembling that of wild-type TAL cells, whereas the majority of TAL cells in ADTKD-UMOD showed only sparse 
and more punctuated intracytoplasmic SDHA staining. Ultrastructural analyses of wild-type TAL cells revealed 
Figure 1. Disturbance of ER homeostasis in ADTKD-UMOD. (A) ADTKD-UMOD is characterized 
by maturation and trafficking defect of mutant UMOD and intracellular accumulation of UMOD in TAL 
cells. UMOD immunolocalization revealed a diffuse cytoplasmic staining with enforcement of the luminal 
membrane in TAL cells of a wild-type mouse. In contrast, TAL cells of an UmodC93F mutant mouse displayed a 
strong paranuclear immunopositivity for UMOD. Wild-type: Umodwt mouse; UmodC93F: homozygous UmodC93F 
mutant mouse. Age of mice analysed: four months. Chromogen: DAB, nuclear staining: haemalum. (B) Heat 
map of relative expression values (z scores) showed differential abundance of several proteins localized in the 
ER. (C) In the outer medulla of Umod mutant mice of both mouse lines, a strong accumulation of immature 
UMOD was present. (D) Protein abundances of BiP, phospho-eIF2α , eIF2α , ATF4, both full-length (§) and 
cleaved activated (#) ATF6, and CHOP were increased in Umod mutant mice compared to wild-type mice. 
Signal intensities were corrected for GAPDH signal intensities of the same PVDF-membrane, which was 
stripped several times to facilitate the detection of multiple proteins. Mean of protein abundance of wild-type 
mice was set on a value of 1 [mean (wild-type) = 1]. Data are shown as means ± SD. One-way ANOVA with 
Newman-Keuls’s post hoc test: p vs. wild-type, *p < 0.05; **p < 0.01; ***p < 0.001.
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Figure 2. Disturbance of mitochondrial homeostasis in ADTKD-UMOD. (A) Z score heat map showed 
differentially abundant proteins localized in mitochondria. (B) In the outer medulla of Umod mutant mice, 
SDHA was less abundant compared to wild-type mice. Signal intensities were corrected for GAPDH signal 
intensities of the same PVDF-membrane. Mean of protein abundance of wild-type mice was set on a value of 
1 [mean (wild-type) = 1]. One-way ANOVA with Newman-Keuls’s post hoc test: p vs. wild-type, **p < 0.01; 
***p < 0.001. (C) Immunolocalization of SDHA revealed high abundance of SDHA in TAL segments of a 
wild-type mouse, whereas collecting duct cells (star) exhibited only weak SDHA immunostaining. Higher 
magnification of TAL cells demonstrated homogenous lamellar basal orientated cytoplasmic immunolocalization 
of SDHA in wild-type. In contrast, SDHA staining of TAL segments of the UmodC93F mutant mouse was 
heterogeneous. Few TAL cells exhibited a SDHA staining intensity and pattern resembling that of wild-type TAL 
cells but were less compact, whereas the majority of TAL cells in the UmodC93F mutant mouse had only sparse and 
more punctuated intracytoplasmic SDHA staining. Insert shows immunohistochemical localization of UMOD of 
the corresponding region of the outer medulla of the kidney. Wild-type: Umodwt mouse; UmodC93F: homozygous 
UmodC93F mutant mouse. Age of mice analysed: four months. Chromogen: DAB, nuclear staining: haemalum. 
(D) TAL cells of the wild-type mouse exhibited a well-formed basal labyrinth that stands perpendicularly on the 
basement membrane and where elongated mitochondria of crista type (insert) are parallel arranged. In TAL cells 
of UmodC93F mutant mice, numerous predominantly paranuclear bundles (arrowhead) were present identified 
previously as hyperplastic ER6, which were heterogeneous pronounced in different TAL cells. In contrast to 
wild-type, TAL cells of the Umod mutant mouse had a poorly shaped (arrow) or even absent basal labyrinth. 
Further, mitochondria were loosely distributed in the cytoplasm, partly intervening in between the hyperplastic 
bundles of the perinuclear ER. Morphology of mitochondria varied in size and shape, and mitochondria were 
present exhibiting both crista and tubulus types (insert). Occasionally, mitophagy bodies were observed (star). 
Magnification is indicated in inserts. Age of mice analysed: four months.
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a distinctive basal labyrinth with numerous invaginations of the basal cell membrane, with exception of the per-
inuclear region where a small region of the cell membrane did not form invaginations (Fig. 2D). Close to the 
membrane invaginations, elongated mitochondria of the crista type were accumulated in parallel arrangement in 
the compartments of the basal labyrinth and looked homogeneous. In contrast, TAL cells of Umod mutant mice 
had a poorly shaped or even absent basal labyrinth. Furthermore, mitochondria were loosely distributed in the 
cytoplasm, partly intervening in between the hyperplastic bundles of the perinuclear endoplasmic reticulum. 
Morphology of mitochondria varied in size and shape, and mitochondria were present exhibiting both crista and 
tubulus types. Occasionally, mitophagy bodies were observed (Fig. 2D).
Reduced abundance of FIS1 points to disturbed fission of mitochondria in ADTKD-UMOD. The 
life cycle of mitochondria involves biogenesis from newly synthesized proteins, fusion and fission to regulate 
mitochondrial dynamics, and mitophagy as final step of quality control7,8. In addition, fission provides a mech-
anism for selective clearance of damaged components in mitochondria thereby extending their life span. Since 
FIS1 is essentially involved in mitochondrial fission, abundance and localization of this protein was analysed. 
FIS1 was significantly reduced in the outer medulla of ADTKD-UMOD compared to wild-type kidneys (Fig. 3A). 
In TAL cells of wild-type mice, FIS1 was highly abundant and localized in the cytoplasm with a similar staining 
pattern as seen for SDHA and little variability among TAL cells (Fig. 3B, Supplementary Fig. 3B). In contrast, FIS1 
staining of TAL segments of Umod mutant mice was heterogeneous, with only some TAL cells showing a simi-
lar FIS1 staining pattern as seen in wild-type mice. In numerous ADTKD-UMOD TAL cells, FIS1 staining was 
limited to the cytoplasmic borders with nearly negative cytoplasmic staining of the perinuclear region. Impaired 
fission is also supported by the altered morphology of mitochondria in ADTKD-UMOD TAL cells (Fig. 2D).
Fission is also an essential step in the biogenesis and life cycle of peroxisomes9,10. Peroxisomes are dynamic 
organelles involved in lipid metabolism which respond to environmental stimuli. Interestingly, 10 peroxisomal 
proteins were less abundant in the outer medulla of ADTKD-UMOD compared to control kidneys, and only one 
(HAO2) was more abundant (Fig. 3C, Supplementary Table 6), suggesting impaired biogenesis of peroxisomes.
Autophagy of mitochondria as a putative adverse outcome of impaired life cycle mitochondrial 
dynamic in ADTKD-UMOD. To address changes in mitophagy, LC3A and LC3B as markers for organelle 
autophagy were analysed (Fig. 3D). Kidneys of Umod mutant mice exhibited an increased abundance of LC3A 
and LC3B. Both proteins exist in isoforms I and II. During autophagosome formation and maturation, isoform I 
(16 kDa) is converted to isoform II (14 kDa). In Umod mutant mice, the ratio of isoform II/isoform I was signif-
icantly increased for both LC3A and LC3B, suggesting increased organelle autophagy in ADTKD-UMOD. Of 
note, occasionally, mitophagy bodies were observed in TAL cells of Umod mutant mice (Fig. 2D).
Impaired maturation and processing of NRF1 suggests disturbed transcriptional regulation of 
mitochondrial biogenesis. Mitochondrial biogenesis requires transcription of genes encoding mitochondrial 
proteins. In this context, PGC-1α and PGC-1β play a crucial role as transcriptional co-activators11. The abun-
dances of PGC-1α and PGC-1β in kidney samples were not different between Umod mutant and wild-type mice 
(Fig. 4A). Next, we analysed NRF transcription factors, which are co-activated by PGC-1α 11. The glycoprotein 
NRF1 can occur in various kDa sizes due to complex post-translational processing and modification (glycosyl-
ation/deglycosylation, proteolytic cleavage) which are relevant for its transactivation activity12. After translation 
in a 95-kDa full-length protein, NRF1 becomes glycosylated to a non-active 120-kDa isoform in the ER lumen. 
Thereafter, NRF1 is translocated from the ER to the nucleus as a de-glycosylated active 95-kDa transcription fac-
tor. Further, NRF1 can be subjected to proteolytic processing resulting in shorter isoforms. In ADTKD-UMOD 
affected kidneys, the abundance of the glycosylated 120-kDa NRF1 isoform and – to a lesser extent – of a 
65–70-kDa NRF1 isoform was increased, whereas the abundance of the 95-kDa full-length non-/de-glycosylated 
NRF1 isoform was similar between Umod mutant mice and wild-type mice (Fig. 4A). Immunolocalisation 
revealed a discreet nuclear staining of NRF1 in TAL cells of wild-type mice (Fig. 4B). In contrast, Umod mutant 
mice exhibited additionally to the discreet nuclear staining a distinct paranuclear immunopositivity of variable 
intensities of NRF1 in TAL cells. As shown by multicolour immunofluorescence analysis, paranuclear accumu-
lation of NRF1 was co-localized with UMOD (Fig. 4C), the latter was previously demonstrated to be accumu-
lated in the enlarged ER of TAL cells in ADKTD-UMOD6. Entrapment of NRF1 in the hyperplastic ER of TAL 
cells in ADTKD-UMOD associated with accumulation of glycosylated 120-kDa NRF1 isoform is consistent with 
impaired maturation, processing and activation of NRF1 in ADTKD-UMOD.
Disturbed cellular energy homeostasis in ADTKD-UMOD affected kidneys. As powerhouse of 
the cell, energy in form of ATP is mainly derived by aerobic respiration in mitochondria10. Numerous proteins 
of both OXPHOS (25 differentially abundant proteins) and citrate cycle (12 proteins) were strongly reduced 
in abundance in ADTKD-UMOD, affecting all five mitochondrial respiratory complexes of OXPHOS (Fig. 5A, 
Supplementary Table 7). Eight detected differentially abundant proteins were proteins involved in glucose met-
abolic process, thereof PGD showed increased and the other seven reduced abundance in ADTKD-UMOD 
(Fig. 5A, Supplementary Table 7). Three of them (HK1, MDH2 and PDHA1) are localized in mitochondria. 
PGD has a role in oxidative pentose phosphate pathway. Of note, GAPDH was similar abundant in LC-MS/MS 
analyses of outer medulla of wild-type and Umod mutant mice. Decreased abundances of numerous proteins 
involved in glycolysis, OXPHOS and citrate cycle indicate that several metabolic pathways for cellular energy sup-
ply were negatively affected. Therefore, we next analysed the cellular energy sensor AMP-activated protein kinase 
(AMPK), which is activated by phosphorylation in response to energy depletion13. Consistent with the assump-
tion of a negative energy balance in ADTKD-UMOD affected kidneys, the levels of phosphorylated AMPKα were 
significantly increased (Fig. 5B). Next, we analysed the cellular energy sensing signalling kinase LKB1 which is 
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able to phosphorylate and thereby to activate AMPK14. The levels of phosphorylated LKB1 were distinctly higher 
in kidneys of Umod mutant mice than in controls, supporting activation of the LKB-AMPK pathway in response 
to disturbed energy homeostasis in ADTKD-UMOD affected kidneys (Fig. 5B). LKB1 or AMPK can be activated 
Figure 3. Reduction of FISSION 1 indicates disturbance in biogenesis and life cycle of mitochondria and 
peroxisomes, and increase of LC3A and LC3B indicates discreet increase of organelle autophagy. (A) In 
the outer medulla of Umod mutant mice, FIS1 was reduced abundant compared to wild-type mice, thereby the 
reduction was more pronounced in homozygous UmodC93F than in homozygous UmodA227T mutant mice. (B) In 
TAL cells of the wild-type mouse, FIS1 was highly abundant and were immunolocalized in the cytoplasm with 
nearly similar staining pattern as seen for SDHA, with high homogeneity between TAL segments. In contrast, 
FIS1 staining of TAL segments of the homozygous UmodC93F mutant mouse was heterogeneous, where only 
some TAL cells had a similar FIS1 staining pattern as seen in TAL cells of the wild-type mouse. In numerous 
TAL cells of the homozygous UmodC93F mutant mouse, FIS1 seemed to be displaced to the cytoplasmic 
borders of the cells with nearly negative staining predominantly of the paranuclear regions of TAL cells. Insert 
shows immunohistochemical localization of UMOD of the corresponding region of the outer medulla of the 
kidney. Wild-type: Umodwt mouse; UmodC93F: homozygous UmodC93F mutant mouse. Age of mice analysed: 
four months. Chromogen: DAB, nuclear staining: haemalum. (C) Z score heat map showed differentially 
abundant proteins localized in peroxisomes. (D) In the outer medulla of Umod mutant mice, LC3A and LC3B 
were increased abundant compared to wild-type mice. Further, LC3-II vs. -I ratios of LC3A and LC3B were 
significantly increased in Umod mutant mice indicating an increase of autophagy due to increased conversion 
of isoform I (16 kDa) into isoform II (14 kDa) of LC3. (A & D) Signal intensities of immunoblots were corrected 
for GAPDH signal intensities of the same PVDF-membrane. Mean of protein abundance of wild-type mice was 
set on a value of 1 [mean (wild-type) = 1]. Data are shown as means ± SD. One-way ANOVA with Newman-
Keuls’s post hoc test: p vs. wild-type, *p < 0.05; **p < 0.01; ***p < 0.001.
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Figure 4. Disturbed post-translational processing of NRF1 abrogates transcriptional regulation of 
mitochondrial biogenesis by NRF1. (A) Relative protein abundances of PGC-1α , PGC-1β and NRF1 in the 
outer medulla of Umod mutant mice and wild-type mice. § 120-kDa inactive ER-resident NRF1 glycoprotein,  
# 95-kDa full-length non-glycosylated protein (precursor) and/or active de-glycosylated isoforms of NRF1,  
$ 65–70-kDa isoform of NRF1. Signal intensities were corrected for GAPDH signal intensities of the same 
PVDF-membrane. Mean of protein abundance of wild-type mice was set on a value of 1 [mean (wild-type) = 1]. 
Data are shown as means ± SD. One-way ANOVA with Newman-Keuls’s post hoc test: p vs. wild-type, *p < 0.05; 
**p < 0.01; ***p < 0.001. Wild-type: Umodwt mice; UmodC93F: homozygous UmodC93F mutant mice; UmodA227T: 
homozygous UmodA227T mutant mice. (B) Immunohistochemical localization of NRF1. In TAL cells of the 
wild-type mouse, NRF1 was discreet abundant in nuclei. In contrast, the UmodC93F mutant mouse exhibited 
additionally to the discreet nuclear staining a distinct paranuclear immunopositivity of variable intensities 
of NRF1 in TAL cells. Cells of TAL segment were identified by UMOD immunostaining. Wild-type: Umodwt 
mouse; UmodC93F: homozygous UmodC93F mutant mouse. Age of mice analysed: four months. Chromogen: 
DAB, nuclear staining: haemalum. (C) Co-localization of uromodulin and NRF1 in TAL cells of a four-month-
old homozygous UmodC93F mutant mouse, studied by multicolour immunofluorescence analysis. UMOD is 
known to be accumulated in the hyperplastic endoplasmic reticulum (ER) of TAL cells in ADTKD-UMOD. 
Co-localization of NRF1 with UMOD is indicative for accumulation of NRF1 also in the ER of TAL cells. Some 
nuclei exhibited a discreet NRF1 immunofluorescence with distinct nuclear foci. DAPI: nuclear marker.
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by ATM, a critical early DNA damage response protein14. However, the abundance of ATM was similar in kidneys 
of Umod mutant and wild-type mice.
Figure 5. Disturbed cellular energy homeostasis in ADTKD-UMOD affected kidneys. (A) Z score heat maps 
showed differentially abundant proteins involved in OXPHOS, citrate cycle and glucose catabolic process.  
(B) The phosphorylation of AMPKα was increased in the outer medulla of UmodA227T and UmodC93F mutant 
mice compared to wild-type mice, indicating an impaired cellular energy homeostasis in ADTKD-UMOD. 
Protein abundance of AMPKα was similar between different genotypes. The phosphorylation of LKB1 was 
increased in the outer medulla of UmodA227T and UmodC93F mutant mice compared to wild-type mice, further 
supporting existence of energy depletion in ADTKD-UMOD. Protein abundance of LKB1 was similar between 
different genotypes. Also ATM abundance was similar irrespective of genotype. Signal intensities were corrected 
for GAPDH signal intensities of the same PVDF-membrane. Mean of protein abundance of wild-type mice was 
set on a value of 1 [mean (wild-type) = 1]. Data are shown as means ± SD. One-way ANOVA with Newman-
Keuls’s post hoc test: p vs. wild-type, *p < 0.05; **p < 0.01; ***p < 0.001.
www.nature.com/scientificreports/
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Early signs of renal fibrotic processes in ADTKD-UMOD. Ten extracellular matrix proteins with 
increased abundances were identified in the outer medulla of ADTKD-UMOD affected kidneys compared to 
wild-type controls (Supplementary Fig. 4, Supplementary Table 8). Highest increase in the abundance exhibited 
COL1A1, COL14A1 and LUM (log2 fold change: 2.5, 2.1 and 1.8, respectively).
Discussion
ADTKD-UMOD is caused by amino acid changing mutations of UMOD which lead to a pronounced protein 
maturation and secretion defect of both mutated and native UMOD, massive accumulation of immature UMOD 
in the enlarged ER of TAL cells and strongly reduced urinary UMOD excretion1,6. Protein maturation defects of 
UMOD cause a strong disturbance of the ER homeostasis, ER stress and induction of UPR. These events are asso-
ciated with pronounced morphological alterations in TAL cells like massive enlargement of the ER.
Based on the results of our holistic proteome analysis of the ADTKD-UMOD mouse model, we can 
extend the flowchart of pathophysiological events and their impact on TAL cell morphology and function in 
ADTKD-UMOD (Fig. 6).
Upregulation of numerous ER proteins, involved in protein folding, quality control, intra-ER-transport and 
glycosylation, may be interpreted as an attempt of the TAL cells to promote maturation and urinary secretion of 
mutant UMOD protein. These cellular efforts are at least partially successful, as demonstrated by low amounts of 
UMOD in urine of homozygous Umod mutant mice6. However, ER overload also negatively affects maturation 
and processing of native UMOD protein1,6,15 and of other proteins like the mitochondrial transcription factor 
NRF1, thereby inhibiting its activation and nuclear translocation (see below).
Long-lasting ER stress and UPR resulted in strong activation of the NF-κ B pathway4 and, as shown in the 
present study, of the eIF2α-ATF-CHOP pathway and – to a lesser extent – of the ATF6 pathway. Increased levels 
of ER proteins ERO1L, HYOU1 and TXNDC5, which are induced as cellular response to hypoxia16–18, might 
have protective effects on TAL cells. Stress survival functions under hypoxia were described for HYOU1 and 
Figure 6. Flowchart of the pathophysiology of ADTKD-UMOD and its impact on TAL cell morphology. 
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TXNDC5 18,19. Of note, CHOP induces upregulation of the anti-apoptotic factor HYOU120, and HYOU1 can con-
trol the activity of the pro-apoptotic protein CHOP21. Up-regulation of survival factors like HYOU1 or TXNDC5 
might thus protect TAL cells from apoptosis despite increased CHOP abundance. This might contribute to the 
slow progression of ADTKD-UMOD in our Umod mutant mice and in affected patients.
How can ER hyperplasia and chronic ER stress affect mitochondria? Biogenesis of mitochondria requires tran-
scriptional activation of genes encoding mitochondrial proteins7. The transcription factor PGC-1 and its essential 
co-activator NRF1 play a critical role in mitochondrial biogenesis22. Accumulation of the inactive glycosylated 
isoform of NRF1 in the hyperplastic ER of TAL cells likely contributes to reduced mitochondrial mass and dys-
function in ADTKD-UMOD. In addition, spatial interaction with the ER is relevant for mitochondrial biogenesis 
by fission10,23. Mitochondria can dynamically respond to environmental stimuli by fusion and fission9,10. These 
processes are also important for mitochondria to get rid of damaged mitochondrial proteins and thereby to pro-
long life time of mitochondria8. FIS1 in TAL cells of Umod mutant mice was decreased in abundance and showed 
altered cellular distribution, pointing to reduced fission activity of mitochondria. This assumption is supported by 
the heterogeneous morphology of mitochondria in TAL cells of Umod mutant mice. The abundance of LONP1, a 
mitochondrial protease involved in degradation of damaged proteins and in mitochondrial quality control under 
stress conditions24,25, was increased in ADTKD-UMOD suggesting the occurrence of stressed mitochondria, 
which might be more susceptible to enter the mitophagy process.
Besides its impact on mitochondrial biogenesis, ER stress can also influence the function of mitochondria. The 
physical contact site between ER and mitochondria is the mitochondria-associated membrane (MAM), a critical 
signalling platform facilitating calcium and lipid transfer between these organelles26. The MAM alters its set of 
regulatory proteins and functions during cellular stress. Several MAM proteins were differentially abundant in 
ADTKD-UMOD. The abundance of ACAT1, often used as marker of MAM (reviewed in ref. 26), was decreased, 
while the MAM proteins ERO1L27 and BiP26 were increased abundant in ADTKD-UMOD. Altered levels of sev-
eral MAM proteins suggest disturbed signalling between chronically stressed ER and mitochondria.
Strong reduction of proteins of OXPHOS and citrate cycle, and an increase of numerous hypoxia-inducible 
proteins in ADTKD-UMOD point to impaired energy homeostasis of TAL cells. This is supported by increased 
activation of the LKB1-AMPK axis, the sensor pathway of cellular energy status14. Interestingly, PGD, a central 
enzyme of the pentose phosphate pathway, was more abundant in UmodC93F mutant mice than in wild-type con-
trols. Activation of the pentose phosphate pathway could provide an alternative energy supply to mitochondrial 
ATP synthesis (Warburg effect)28. LONP1, which was higher abundant in ADTKD-UMOD, can favour the switch 
from a respiratory to a glycolytic metabolism25,29.
Besides their function as powerhouse of the cell, mitochondria are critically involved in intracellular calcium 
handling and apoptosis signalling30,31. Mitochondrial dysfunction is known to play a critical role in the patho-
genesis of kidney diseases30. Ultrastructural studies of TAL cells of ADTKD-UMOD patients described TAL cells 
with fibrillar material mostly evident in ER with smaller area overrunning mitochondria32 or TAL cells contain-
ing hyperplastic ER bundles with few intervening mitochondria alternating with areas of dilated ER containing 
storage material33. These reports underline the clinical relevance of mitochondrial alterations uncovered by the 
present study in ADTKD-UMOD mouse model. Mitochondrial changes are already present in an early stage of 
the disease and likely contribute to TAL dysfunction and disease progression.
In conclusion, the proteomic alterations identified in this study mirror the pronounced structural alterations 
of TAL cells in the ADTKD-UMOD mouse model, which are also described in human patients. Apart from 
well-known ER stress, mitochondrial dysfunction and altered energy homeostasis are newly identified important 
components in ADTKD-UMOD pathophysiology and may provide novel targets for so far not available thera-
peutic strategies.
Materials and Methods
Mouse models for ADTKD-UMOD. All animal experiments were approved by local government author-
ities (Regierung von Oberbayern) in accordance with the German Animal Welfare Act and conformed to the 
Guide for the Care and Use of Laboratory Animals as published by the US National Institutes of Health. The 
two well established mouse models of ADTKD-UMOD, UmodA227T and UmodC93F, were used6,15. Both Umod 
mutant mouse lines exhibit key features of ADTKD-UMOD like dominant-negative effect of mutant UMOD 
protein with maturation defect and retention of UMOD in the hyperplastic endoplasmic reticulum of TAL cells 
and impaired kidney function with mild defect in urinary concentration ability, reduced fractional excretion of 
uric acid, and reduced uromodulin excretion. Although UmodA227T and UmodC93F mutant mice exhibit similar 
disease phenotype, UmodC93F mutant mice are earlier and more severely affected by a more pronounced mutant 
UMOD maturation defect and TAL dysfunction. Homozygous mutant mice exhibit a more pronounced disease 
phenotype than heterozygous mutants of the same line. A correlate of the UmodC93F mutation exists in humans, 
where ADTKD-UMOD affected patients were identified harbouring disease-causing mutations p.C94W (human 
UMODC94 corresponds to murine UmodC93) and p.C106G, p.C106Y, p.C106F (human UMODC106 corresponds to 
murine UmodC105) leading to disruption of a putative disulphide bond C94-C106 in human UMOD (respectively 
C93-C105 in murine UMOD) (Wake Forest Inherited Kidney Disease Registry, http://www.ukdcure.org/muta-
tion_catalog)6. Both UmodA227T and UmodC93F mutant mouse lines were maintained in the C3HeB/FeJ (C3H) 
genetic background and housed in a specific pathogen-free mouse facility. All mice had access to food (V1124-3, 
Ssniff, Soest, Germany) and water ad libitum and mouse husbandry was performed under standard environment 
conditions (22 ± 2 °C, 40–50% relative humidity, 12 h light/dark cycle).
Sample preparation for proteome analyses. TAL segments are the primary site of injury in 
ADTKD-UMOD and the TAL segment density in the kidney is highest in the outer medullar region. Using the 
outer medulla was proven to enable evaluation of pathophysiology of ADTKD-UMOD in a previous study4. 
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In vitro models using mutant UMOD transfected cells were previously described by others to do not mirror the 
key cellular hallmarks of ADTKD-UMOD, which are mutant UMOD aggregation, ER membrane expansion, and 
ER dilation, and was therefore reported to be not suitable to analyse potential disease mechanisms downstream of 
mutant UMOD retention in ADTKD-UMOD1. The outer medulla was prepared as described4. Briefly, each fresh 
kidney of four-month-old mice was cut along the midsagittal plane into two halves and further into transverse 
slices. The outer medulla were then received by removing the cortex and inner medulla, shock frozen on dry ice 
and stored at − 80 °C until further use for mass spectrometry or Western Blot analyses. Always the whole prepa-
ration of the outer medulla of one kidney was used for sample homogenization. Four-month-old mice were used 
in this study. At this age the ADTKD-UMOD phenotype is already clinically present in Umod mutant mice of 
both lines, but is in an early disease stage where no progressed morphological kidney alterations like interstitial 
fibrosis, tubular atrophy, or infiltrates of inflammatory cells are present (Supplementary Fig. 5).
Sample preparation for and performance of quantitative LC-MS/MS. The outer medulla of five 
four-month-old male homozygous UmodC93F mutant mice and age-matched wild-type littermate controls was 
homogenized in a MS lysis buffer containing 8 M urea and 0.4 M NH3HCO3. Protein concentrations were deter-
mined with a 660 nm assay (Thermo-Scientific). Prior to tryptic digestion, protein concentrations were adjusted 
to 1 mg/ml with MS lysis buffer. DTE to a final concentration of 4 mM was added to 100 μ g protein in 100 μ l (conc. 
1 mg/ml), and incubated for 30 min at room temperature. Next, cysteine residues were blocked by addition of 
iodoacetamide to a final concentration of 8 mM and further incubated for 30 min in the dark. After dilution with 
water to give a concentration of 1 M urea, 2 μ g porcine trypsin (Promega, Madison, WI, USA) was added and 
incubated overnight at 37 °C.
Peptide samples were analysed by LC-MS/MS analysis using an UltiMate 3000 nano LC system (Thermo 
Scientific, Waltham, MA, USA) connected to a TripleTOF 5600+ mass spectrometer (Sciex, Concord, Canada). 
2.5 μ g of peptides diluted in chromatography solvent A (0.1% formic acid) were transferred at a flow rate of 
30 μ l/min to a trap column (Acclaim PepMap 100, μ -Precolumns, 5 mm × 300 μ m, 5 μ m particles, Thermo 
Scientific) and separated at a flow rate of 200 nL/min with a 50 cm separation column (Acclaim PepMap RSLC C18, 
75 μ m × 50 cm, 2 μ m, Thermo Scientific). Consecutive gradients, from 2% to 25% solvent B (0.1% formic acid, 
100% ACN) in 260 min and from 25% to 50% solvent B in 60 min were used. MS spectra were acquired (positive 
ion mode) in cycles of one MS scan (mass range m/z 200–1800) followed by ten data dependent CID MS/MS 
scans (collision energy 45).
Data analysis of quantitative LC-MS/MS derived holistic proteome analysis. MS wiff files were 
processed using MaxQuant version 1.5.1. As protein databases, the Mus musculus subset of the UniProt and 
the MaxQuants common contaminants database was used. For database searches the MaxQuant default values 
for Sciex TOF instruments and a protein FDR of 1% was applied. The quantification was performed with the 
label-free quantification (LFQ) strategy implemented in MaxQuant. Statistics as well as the heatmap generation 
was performed using the Perseus module, part of the MaxQuant software pipeline. In cases where proteins were 
detected in at least three samples of one group, the “imputation form normal distribution” feature implemented 
in Perseus was used. For statistical evaluation a two sided T-test and a permutation-based FDR estimation was 
performed.
To identify functional relationships among differentially abundant proteins identified by quantitative LC-MS/MS 
analysis, we used the DAVID bioinformatics online tool for functional annotation clustering34. The annotation cat-
egories used in our DAVID cluster enrichment analysis were the functional category SP_PIR_KEYWORDS, UP_
SEQ_FEATURE, the gene ontology terms GOTERM_BP_FAT, GOTERM_CC_FAT, and GOTERM_MF_FAT, 
and KEGG_PATHWAY; analysis was performed with high classification stringency. We considered functional 
clusters having enrichment score of greater than 2 and individual Fisher’s exact and of Benjamini P values of less 
than 0.05 for each term in the cluster.
Western blot analyses. The outer medulla of four-month-old homozygous UmodC93F mutant mice, 
homozygous UmodA227T mutant mice and wild-type mice was homogenised in Laemmli extraction buffer and 
protein concentration was determined by BCA assay. 15 μ g of denatured tissue lysate per lane was separated 
on SDS-polyacrylamide minigels and blotted on PVDF membranes. Equal loading was controlled by Ponceau 
staining. The following primary antibodies were used: rabbit monoclonal antibody against phospho-AMPKα 
(Thr172) (40H9, no. 2535, Cell Signaling), rabbit polyclonal antibody against AMPKα (no. 2532, Cell Signaling), 
rabbit monoclonal antibody against ATF4 (D4B8, no. 11815, Cell Signaling), mouse monoclonal antibody against 
ATF6 (70B1413.1, no. NBP1-40256, novusbio), rabbit monoclonal antibody against ATM (D2E2, no. 2873, Cell 
Signaling), rabbit polyclonal antibody against BiP (no. 3183, Cell Signaling), rabbit monoclonal antibody against 
CHOP (D46F1, no. 5554, Cell Signaling), rabbit polyclonal antibody against FIS1 (no. GTX111010, GeneTex), 
rabbit monoclonal antibody against GAPDH (D16H11, no. 5174, Cell Signaling), rabbit monoclonal antibody 
against LC3A (D50G8, no. 4599, Cell Signaling), rabbit monoclonal antibody against LC3B (D11, no. 3868, Cell 
Signaling), rabbit monoclonal antibody against phospho-LKB1 (Ser428) (C67A3, no. 3482, Cell Signaling), rab-
bit monoclonal antibody against LKB1 (D60C5, no. 3047, Cell Signaling), rabbit polyclonal antibody against 
NRF1 (no. 12381, Cell Signaling), rabbit polyclonal antibody against PGC-1α (no. NBP1-04676, novusbio), 
mouse monoclonal antibody against PGC-1β (no. sc-373771, Santa Cruz), rabbit monoclonal antibody against 
SDHA (D6J9M, no. 11998, Cell Signaling), and rabbit polyclonal antibody against human THP (H-135, no. 
sc-20631, Santa Cruz Biotechnology). Three antibodies against NRF2 (RnD Systems no. MAB3925, Cell 
Signaling no. 12721, and proteintech no. 16396-1-AP) were tested but failed to detect NRF2 protein. ECL reagent 
(GE Healthcare Amersham Biosciences) was used for visualization of bound antibodies. Signal intensities were 
quantified using ImageQuant (GE Healthcare). Standardization of equal loading was referred to the signal 
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intensities of GAPDH of the corresponding PVDF membrane. Data are shown as means ± SD. Data were ana-
lysed by using 1-way ANOVA with Newman-Keuls’s post hoc test. 24-h urine samples, standardized for equal 
creatinine levels, were used for Western blot analysis to detect urinary UMOD content.
Immunohistological and ultrastructural analyses. Fixation of kidneys with 4% paraformaldehyde, 
paraffin embedding and sectioning and histological analyses of kidneys were performed as described previously4,6. 
For multicolour immunofluorescence analyses of UMOD with SDHA and UMOD with FIS1, kidneys were fixed 
in methacarn fixative. Immunohistochemistry was performed using the following primary antibodies: rabbit poly-
clonal antibody against FIS1 (no. GTX111010, GeneTex), rabbit polyclonal antibody against NRF1 (no. 12381, Cell 
Signaling), rabbit monoclonal antibody against SDHA (D6J9M, no. 11998, Cell Signaling), and rat monoclo-
nal antibody against mouse uromodulin (clone 774056; R&D Systems). Immunoreactivity was visualized using 
3,3-diaminobenzidine tetrahydrochloride dihydrate (DAB) (brown colour). Nuclear counterstaining was done 
with haemalum (blue colour). Colocalizations of UMOD with NRF1, UMOD with SDHA and UMOD with FIS1 
were studied by multicolour immunofluorescence analysis, using the above mentioned primary antibodies. All 
secondary antibodies were produced in donkey and coupled to FITC or Cy3 (Dianova). Embedding of slides 
was done with Vectashield antifade solution (Vector Laboratories) containing DAPI as a nuclear counterstain. 
Fluorescence analyses were performed using a confocal laser scanning microscope (LSM 710, Zeiss).
Fixation of kidneys with 3% glutaraldehyde in PBS (pH 7.2) and procession to ultrathin sections for transmis-
sion electron microscopic analyses was performed as described previously6.
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